Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence (Q45270626)

11 December 2017

title

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence (English)

1 reference

11 December 2017

0 references

Helen Marie Pettinati

1

object named as

Helen M Pettinati

1 reference

11 December 2017

Bernard L Silverman

2

1 reference

11 December 2017

John J Battisti

3

1 reference

11 December 2017

Robert Forman

4

1 reference

11 December 2017

Edward Schweizer

5

1 reference

11 December 2017

David R Gastfriend

6

1 reference

11 December 2017

publication date

16 May 2011

1 reference

Alcoholism: Clinical and Experimental Research

11 December 2017

published in

1 reference

11 December 2017

volume

35

1 reference

11 December 2017

issue

10

1 reference

11 December 2017

page(s)

1804-1811

1 reference

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Tobacco use is associated with more severe alcohol dependence, as assessed by the number of DSM-IV criteria, in Swedish male type 1 alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Family transmission and heritability of externalizing disorders: a twin-family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Handling drop-out in longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Is there a future for quantifying drinking in the diagnosis, treatment, and prevention of alcohol use disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Association between psychiatric symptoms and severity of alcohol dependence in a sample of brazilian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Behavioral couples and family therapy for substance abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Genetic and environmental effects on conduct disorder and alcohol dependence symptoms and their covariation at age 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Toward an alcohol use disorder continuum using item response theory: results from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Recovery from alcohol problems with and without treatment: prevalence in two population surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

Cox's Regression Model for Counting Processes: A Large Sample Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2011.01524.X

10.1111/J.1530-0277.2011.01524.X

21 January 2018

Identifiers

DOI

1 reference

release_qo7hbddzxfhtda5gwrzid3m6zm

11 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qo7hbddzxfhtda5gwrzid3m6zm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference